Skip to content
lifestyle.ucconnection.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AlzeCure Pharma
AlzeCure Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference on September 2
August 27, 2026
AlzeCure Receives a USD 10 Million Upfront Payment and Completes Initial Transaction with Lilly
August 18, 2026
AlzeCure Pharma Resolves on a Directed Share Issue to QuantumCell
August 3, 2026
Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer’s
June 16, 2026
AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer’s Project
June 9, 2026
Notice To Annual General Meeting in AlzeCure Pharma AB
May 26, 2026
AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain
May 23, 2026
AlzeCure Pharma to Present at Redeye Investor Forum Online on May 21
May 22, 2026
AlzeCure Pharma to Present at ABG Investor Days on May 21
May 22, 2026
New scientific Article Published on TrkA-NAM ACD137 Against Osteoarthritic Pain
May 21, 2026
1
2
Next Page
→